Stay updated with breaking news from Intelgenx Technologies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SAINT LAURENT, Quebec, April 08, 2024 -- IntelGenx Corp. today announced that Montelukast VersaFilm® has been administered to the first Parkinson’s Disease patients in the Phase 2 clinical...
SAINT LAURENT, Quebec, April 05, 2024 -- IntelGenx Corp. today announced that its co-developer, Chemo Research SL, through its agent and affiliate, Xiromed LLC , has received a Complete Response...
SAINT LAURENT, Quebec, Feb. 20, 2024 -- IntelGenx Corp. today announced the launch of a Regulation A offering of up to 2,000,000 shares of Series A Convertible Cumulative Preferred Stock , par...
IntelGenx Technologies Corp. (CVE:IGX – Get Free Report)’s share price shot up 1.8% during mid-day trading on Thursday . The stock traded as high as C$0.60 and last traded at C$0.58. 11,848 shares were traded during mid-day trading, a decline of 79% from the average session volume of 56,279 shares. The stock had previously closed […]
CHANGES TO BOARD OF DIRECTORS OF GEEKCO